Deccan Health Care reported a significant expansion in both revenue and profitability for the first quarter of FY26. Standalone income from operations rose 53% year-on-year to ₹1,809.9 lakh, up from ₹1,179.8 lakh in Q1FY25. Net profit after tax (PAT) also increased, climbing to ₹10.3 lakh from ₹7.4 lakh in the corresponding period last year.

The quarterly performance reflects improved operational efficiency compared to the prior year, with pre-tax profits holding steady at ₹13.8 lakh against ₹17.3 lakh in Q4FY25. The Board of Directors approved the unaudited standalone and consolidated financial results during its meeting held on August 14, 2026.

Financial Highlights

What the Numbers Show

The divergence between the strong revenue growth and the modest absolute profit figures indicates thin margins. While top-line growth accelerated significantly, the net profit margin remained compressed at approximately 0.57% for the quarter. This suggests that cost structures or input expenses may have scaled in tandem with revenue, limiting the immediate translation of sales growth into bottom-line gains.

Regulatory Compliance

The financial results were filed pursuant to Regulation 33 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The unaudited results are available on the company’s website and the stock exchange platforms.

Deccan Health Care Limited reported a standalone net profit of ₹24.63 lakh for the quarter ended June 30, 2026, marking a 15.9% increase from ₹21.25 lakh in the corresponding period of FY26. The Hyderabad-based nutraceutical manufacturer saw its revenue from operations rise 1.8% year-on-year to ₹2,185.61 lakh, compared to ₹2,146.95 lakh in Q1FY26.

On a consolidated basis, which includes subsidiary Beyoungstore Private Limited, net profit climbed 22.8% to ₹29.11 lakh from ₹23.71 lakh a year ago. Consolidated revenue from operations remained relatively flat at ₹2,206.91 lakh, down marginally from ₹2,214.02 lakh in the prior-year quarter.

The Board of Directors approved the unaudited financial results during a meeting held on August 14, 2026. The results were reviewed by statutory auditors Keyur Shah & Associates pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Standalone Financial Performance

Revenue growth was modest but accompanied by an improvement in profitability metrics. Earnings per share (basic and diluted) stood at ₹0.10, up from ₹0.09 in Q1FY26.

Cost of materials consumed rose to ₹2,247.34 lakh from ₹1,905.21 lakh in the previous year’s quarter. However, this was partially offset by a significant decrease in inventory values, recorded as negative changes of ₹745.48 lakh, compared to ₹361.27 lakh in Q1FY26. Employee benefit expenses declined slightly to ₹120.64 lakh from ₹136.37 lakh.

What the Numbers Show

The divergence between rising material costs and stable revenue highlights the impact of inventory adjustments on the bottom line. While cost of materials consumed increased by approximately 18% year-on-year, the company benefited from a larger reduction in finished goods and work-in-progress inventory (₹745.48 lakh vs ₹361.27 lakh). This inventory drawdown effectively lowered total expenses relative to revenue, supporting the expansion in net profit despite modest top-line growth.

Consolidated Results

The consolidated figures reflect the inclusion of Beyoungstore Private Limited, which contributed ₹259.44 lakh to total income and ₹4.50 lakh to profit after tax for the quarter.

Consolidated earnings per share were ₹0.12, compared to ₹0.10 in the same quarter last year. Other comprehensive income showed a minor loss of ₹0.28 lakh for both standalone and consolidated entities, consistent with the prior year’s pattern.

The company reported no investor complaints pending or received during the quarter. Paid-up equity share capital remained unchanged at ₹2,474.92 lakh.